These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33614284)

  • 61. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
    Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
    Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
    [TBL] [Abstract][Full Text] [Related]  

  • 62. LINC00152 acts as a potential marker in gliomas and promotes tumor proliferation and invasion through the LINC00152/miR-107/RAB10 axis.
    Peng G; Su J; Xiao S; Liu Q
    J Neurooncol; 2021 Sep; 154(3):285-299. PubMed ID: 34478013
    [TBL] [Abstract][Full Text] [Related]  

  • 63.
    Zhu L; Zheng Y; Hu R; Hu C
    Biomed Res Int; 2021; 2021():5486131. PubMed ID: 34631884
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
    Guo SK; Shen MF; Yao HW; Liu YS
    Cell Physiol Biochem; 2018; 49(3):1097-1109. PubMed ID: 30196284
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression and Prognostic Value of Melanoma-Associated Antigen D2 in Gliomas.
    Yan J; Li S; Lenahan C; Chen H; Wen J; Huang Q; Jiang Q; Guo F; Deng T; Mo L
    Brain Sci; 2022 Jul; 12(8):. PubMed ID: 35892426
    [TBL] [Abstract][Full Text] [Related]  

  • 66. LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages.
    Hu WM; Yang YZ; Zhang TZ; Qin CF; Li XN
    Front Med (Lausanne); 2020; 7():182. PubMed ID: 32528967
    [No Abstract]   [Full Text] [Related]  

  • 67. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas.
    Sun H; Long S; Wu B; Liu J; Li G
    PeerJ; 2020; 8():e8787. PubMed ID: 32211242
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TRAF3IP3 promotes glioma progression through the ERK signaling pathway.
    Lin Q; Chen Z; Shen ZL; Xue F; Qin JJ; Kang XP; Chen ZR; Xia ZY; Gao L; Chen XZ
    Front Oncol; 2022; 12():776834. PubMed ID: 36185204
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IGFBP2 expression predicts IDH-mutant glioma patient survival.
    Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
    Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cell division cycle associated 7 like predicts unfavorable prognosis and promotes invasion in glioma.
    Shen FZ; Li XS; Ma JW; Wang XY; Zhao SP; Meng L; Liang SF; Zhao XL
    Pathol Res Pract; 2019 Jan; 215(1):50-56. PubMed ID: 30389317
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma.
    Lv L; Zhang Y; Zhao Y; Wei Q; Zhao Y; Yi Q
    Front Cell Neurosci; 2021; 15():704344. PubMed ID: 34335194
    [No Abstract]   [Full Text] [Related]  

  • 74. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
    Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
    Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Integrin Beta 1 Promotes Glioma Cell Proliferation by Negatively Regulating the Notch Pathway.
    Min W; Zou C; Dai D; Zuo Q; Chen C; Xu J; Li Y; Yue Z
    J Oncol; 2020; 2020():8297017. PubMed ID: 33014056
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis.
    Zimu Z; Jia Z; Xian F; Rui M; Yuting R; Yuan W; Tianhong W; Mian M; Yinlong L; Enfang S
    Front Mol Biosci; 2021; 8():696072. PubMed ID: 34422904
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas.
    Ye L; Xu Y; Wang L; Zhang C; Hu P; Tong S; Liu Z; Tian D
    Cancer Med; 2021 Nov; 10(22):8100-8113. PubMed ID: 34612013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
    Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.